ArticleDiabetes technology & therapeutics2016

ECL-IAA and ECL-GADA Can Identify High-Risk Single Autoantibody-Positive Relatives in the TrialNet Pathway to Prevention Study.

Andrea K Steck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.